Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus - Related Studies

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus

This study has been completed.

Study NCT00004662. Last updated on June 23, 2005. Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Systemic Lupus Erythematosus

2	Additional conditions recognized in this trial
		Lupus Erythematosus, Systemic

3	More general conditions related to this trial
		Autoimmune Diseases
		Connective Tissue Diseases
		Immune System Diseases

4	Interventions listed in this trial
		dehydroepiandrosterone

5	More general drug interventions related to this trial
		Adjuvants, Immunologic
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		National Center for Research Resources (NCRR)
		Northwestern University